Joseph Ziegler serves as Executive at TherapeuticsMD, Inc., where they oversee executive responsibilities. Since joining the company, Joseph Ziegler has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 17, 2023 involved receiving (via award) 7,500 shares valued at $0.
Joseph Ziegler currently holds 7,500 shares of TherapeuticsMD, Inc. (TXMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Ziegler has been a net neutral trader of TXMD stock. They have purchased $0 and sold $0 worth of shares.
Joseph Ziegler's most recent insider trade was on Aug 17, 2023, when they sold 7,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.16 |
| Discretionary |
| Jan 1, 2023 | RXMD | $50.0K | Award | 8,197 | $6.10 | Discretionary |
| Mar 22, 2022 | RXMD | $50.0K | Award | 8,929 | $5.60 | Discretionary |